• Aucun résultat trouvé

Formulaire déclaration nouvelle réaction dynamique (ENG)

N/A
N/A
Protected

Academic year: 2022

Partager "Formulaire déclaration nouvelle réaction dynamique (ENG)"

Copied!
1
0
0

Texte intégral

(1)

NEW ALLERGIC DRUG REACTION REPORTING FORM

User’s last name

First name

File Number

Year Month Day Sex

Date of birth M F

Health Insurance Number Year Month

Expiry date

SUSPECTED DRUGS (List in order of probability)

Drug name Start of treatment End of treatment

Year Month Day Year Month Day

1.

2.

3.

Key Clinical Manifestations

Year Month Day Year Month Day

Started Ended Ongoing

Interval between dose and reaction (e.g., minutes/hours/days)

Cutaneous manifestations Other manifestations Additional information

(Check all that apply) (Check all that apply) (e.g., location of lesions, severity, etc.)

Mucous membrane involvement Gastrointestinal Bullae/pustules Fever > 38 °C Desquamation Hematologic Maculopapular rash Hepatic

Edema Hypotension

Palpable purpura Renal

Urticaria Respiratory

Manifestations disappeared after withdrawal of drug Yes No Not known

Hospitalization required Yes No Not known

If yes, please specify (e.g., emergency department, intensive care unit): Treatment for key clinical manifestations

None Systemic corticosteroid Epinephrine Antihistamine Topical corticosteroid Other:

Response to treatment: Yes No (Please specify):

Current allergy status Referral for allergy consultation

Confirmed allergy: Yes Date

Year Month Day

Suspected allergy: No

Conclusions: Please specify the severity of the observed allergic reaction Immediate allergic reaction (IgE-mediated, or type I)

Severity (Please specify):

Delayed allergic reaction (type II, III or IV) Severity (Please specify):

Not known

License No. Year Month Day

Signature Date

AH-707A DT9309 (2017-02) REACTION REPORTING FORMNEW ALLERGIC DRUG USER’S RECORD

Click on underlined words for instructions.

Instructions Erase Print Save as

Références

Documents relatifs

Figure 1 Correlation between lesional skin levels of cytokine human vascular endothelial growth factor (VEGF) and eczema area and severity index (EASI) score in patients with

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of

A compression stress (like in compression wood) induces a swelling between the grooves thus the longitudinal growth strain is positive.. A tension stress ( like in

As shown in Scheme 19, the reaction of a range of aldehydes 48a–k performed at room temperature in diethyl ether in the presence of 20 mol % of this ligand and 2.25 equivalents of

- Les anticorps (IgG et IgM)  - Les complexes immuns Ag-Ac - le complément (lyse cell.). - Les

Conclusions (Précisez la sévérité de la réaction allergique observée) Réaction immédiate (IgE-médiée ou de type I). Précisez la

– Une fois le diagnostic d’allergie médicamenteuse confirmé par un médecin à l’aide de tests conformes, un nouveau formulaire devrait être rempli afin de mettre à jour

– Indicate whether a health professional suspects an allergy after having observed clinical manifestations suggestive of an allergic reaction but which require further